Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk
Jairam R. Lingappa(University of Namur), Glenda Gray(South African Medical Research Council), Carey Farquhar(University of Washington), Helen Rees(Institute of Mental Health), Wendy Stevens(University of Namur), Anna Wald(University of Washington), Robert W. Coombs(University of Namur), Lawrence Corey(Fred Hutch Cancer Center), Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Max Essex(Harvard University), Richard S. Wang(University of Washington), Connie Celum(University of Washington), Mary S. Campbell(University of Washington), James P. Hughes(University of Namur), James I. Mullins(University of Washington)
Cited by 180
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa
|The Lancet|2004|1.3k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k